Affirmativ Health Licenses Buck RE:Mind for Early Stage Alzheimer’s Sufferers

BELLINGHAM, Wash.–(BUSINESS WIRE)–Affirmativ Health, PLLC (,
has signed a license agreement with the Buck Institute for Research on
Aging (Buck) to offer educational immersion workshops for sufferers of
mild cognitive impairment (MCI), early stage Alzheimer’s disease (AD),
and other early stage dementia types. Affirmativ Health will offer the
RE:Mind workshop leveraging Buck’s pioneering Alzheimer’s research as
the foundation of the program. Affirmativ Health will offer the initial
RE:Mind workshop starting June 27 in Sonoma, CA.

Former Buck VP of Cognitive Wellness, Denise Kalos has joined Affirmativ
Health as COO to continue efforts to expand access to the workshop.
Kalos comments, “I’m excited to join Affirmativ Health. Our team is
poised to build on the strong foundation of the RE:Mind workshops
already completed and to significantly expand our ability to offer the
program around the country and, ultimately, to the rest of the world.”
RE:Mind employs a personalized approach to the multiple metabolic and
genetic facets of an individual’s cognitive health, and focuses
primarily on education and lifestyle adjustments.

Ryan Fortna, MD PhD, a pathologist whose PhD work was focused on the
cell biology of Alzheimer’s disease, will serve as Scientific Director
of Affirmativ Health. He states, “Despite years of intense research
efforts and significant progress on the understanding of the underlying
pathologic basis of Alzheimer’s disease, very little progress has been
made on the therapeutic side by standard medical approaches. While much
of the medical community has ignored alternative approaches, there is
growing evidence that lifestyle modifications, metabolic optimization,
and other non-pharmaceutical approaches provide significant benefit for
sufferers of early cognitive impairment, with results that are in many
ways more impressive than traditional approaches. I am excited to be a
part of the effort to bring this information to the public.”

Neuropathologist John W. Hoyt, M.D., will present a segment of RE:Mind
in June. “Although no effective drug treatment has been discovered to
prevent these dementias, the health and lifestyle changes taught in
these workshops have proven beneficial in enhancing the neuroplasticity
of the brain (i.e. its ability to re-wire itself), and reversing or
slowing cognitive decline.”

Affirmative Health officially opened its doors on May 9, 2016, and is
headquartered in Bellingham, WA.

About Affirmativ Health: Affirmativ Health is passionate about
bringing education, wellness, and hope to those who are affected by
Alzheimer’s disease and other cognitive disorders. We seek to bring the
latest health-conscious science to those with early stage cognitive
decline or genetic predispositions for these disorders. We do this by
educating and supporting these individuals, utilizing the most recent
scientific knowledge on diet, lifestyle and other key factors for
maximizing brain health and fighting the effects of neurodegenerative

About the Buck Institute for Research on Aging: The Buck
Institute is the nation’s first independent research facility focused
solely on understanding the connection between aging and chronic
disease. Our mission is to increase the healthy years of life.

At the Buck Institute, world-class scientists work in a uniquely
collaborative environment to understand how normal aging contributes to
the development of conditions specifically associated with getting older
such as Alzheimer’s and Parkinson’s diseases, cancer, stroke,
osteoporosis, heart disease, diabetes, macular degeneration and
glaucoma. Our interdisciplinary approach brings scientists from
disparate fields together to develop diagnostic tests and treatments to
prevent or delay these maladies.

The stakes have never been higher. While it’s true that people are
living longer, those “extra” years are often marked by disability and
pain. In addition to personal hardship, there is also a cost to society.
The financial burden of treating the chronic diseases of aging is
expected to rise steadily as Baby Boomers get older. There is an urgency
to our mission.

Unlike traditional universities, which have departmental boundaries and
large bureaucracies, the Buck Institute is designed for the free flow of
information. Discoveries quickly result in new studies. Scientists
studying breast cancer are collaborating with researchers examining
aging and nutrition. Parkinson’s disease is being studied in three
different model organisms. A unique inquiry into stem cells and aging is
underway. It’s an exciting place for science that has the potential to
change the way we live.


Affirmativ Health
Denise Kalos
Institute for Research on Aging

Kris Rebillot
Director of
415-209-2080 (office)
415-717-3268 (mobile)